Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05869968
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2023-05-10
Brief Title:
SCIVAX Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI
Sponsor:
Organization:
Northwell Health
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Blood and a self-collected nasal swab will be collected
Enrollment Count:
140
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 95618 |
Who Masked List: